News
-
-
PRESS RELEASE
As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo
NanoViricides announces National Ethics Committee approval for Phase II Clinical Trial of NV-387 Oral Gummies as Treatment for Bundibugyo Ebola; focusing on broad-spectrum antiviral treatment for pandemics -
-
PRESS RELEASE
iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass Retailer
iFabric Corp.'s subsidiary IFTNA launches Aura, a new medical scrubs line integrating PROTX2® and ecoPEL™ technologies with a U.S. retailer, expanding healthcare professionals' access to performance-driven textile solutions -
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Disclosure of voting rights and capital by Eurofins Scientific SE in compliance with transparency regulations. Details on shares and voting rights disclosed -
-
-
-
